Learn how midmarket companies can move AI from pilots to production with focused investments, in-house strategy, expert ...
Former IDEXX, Covetrus and Zomedica executive to lead CompanAIn's next phase of growth CHARLESTON, S.C.--(BUSINESS WIRE)--November 16, 2026-- Compan ...
Serena H. Chen, MD, performs first commercial procedure with newly FDA-approved Juveena, a bioabsorbable hydrogel designed to reduce adhesion reformat ...
Plural’s largest raise to date: almost four times its €260m inaugural fund in 2022, and double its €500m second fund in 2024 * All former founders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results